Scribe

About Scribe

Scribe is a biotechnology company focused on engineering CRISPR-based therapeutics to safely and effectively transform lifetime disease risk. The company highlights a platform and portfolio aimed at genetic medicines with applications across cardiometabolic diseases, oncology, and genomic disorders, pursuing ex vivo and in vivo approaches. Headquartered in the United States, Scribe emphasizes a design-driven, safety-focused engineering philosophy to enable broad access to genetic medicines.